{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:16:55Z","timestamp":1791091015605,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.eururo.2008.11.026","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T11:11:08Z","timestamp":1227697868000},"page":"534-543","source":"Crossref","is-referenced-by-count":155,"title":["Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With \u03b1-Blockers"],"prefix":"10.1016","volume":"56","author":[{"given":"Christopher","family":"Chapple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sender","family":"Herschorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Brodsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2008.11.026_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/nau.20251","article-title":"Reviewing the ICS 2002 terminology report: the ongoing debate","volume":"25","author":"Abrams","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2008.11.026_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2008.11.026_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","article-title":"The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey","volume":"7","author":"Coyne","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.eururo.2008.11.026_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1464-410X.2004.05158.x","article-title":"Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms","volume":"94","author":"Laniado","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)65982-4","article-title":"Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings","volume":"166","author":"Hyman","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11934-002-0095-3","article-title":"Overactive bladder in the male patient: bladder, outlet, or both?","volume":"3","author":"Abdel-Aziz","year":"2002","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.eururo.2008.11.026_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-5347(05)63949-3","article-title":"The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction","volume":"169","author":"de Nunzio","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1464-410X.2003.04719.x","article-title":"The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up","volume":"93","author":"Thomas","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1474-4422(03)00622-7","article-title":"Antimuscarinics for the treatment of overactive bladder","volume":"3","author":"Andersson","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2008.11.026_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib15","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1097\/01.ju.0000181823.33224.a0","article-title":"Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"174","author":"Kaplan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib16","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2006.03.006","article-title":"Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia","volume":"68","author":"Kaplan","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.11.026_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1464-410X.2006.06068.x","article-title":"Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib18","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"issue":"Suppl 2A","key":"10.1016\/j.eururo.2008.11.026_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2006.05.042","article-title":"Development and validation of patient-reported outcomes measures for overactive bladder","volume":"68","author":"Coyne","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2008.11.026_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the Patient Perception of Bladder Condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2008.11.026_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1464-410X.2008.07761.x","article-title":"Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score","volume":"102","author":"Kaplan","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib23","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.juro.2008.05.050","article-title":"Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient-reported outcomes in men with lower urinary tract symptoms","volume":"180","author":"Rovner","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib25","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00029330-200703010-00004","article-title":"Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study","volume":"120","author":"Yang","year":"2007","journal-title":"Chin Med J"},{"key":"10.1016\/j.eururo.2008.11.026_bib27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1001\/jama.280.23.1995","article-title":"Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial","volume":"280","author":"Burgio","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2008.11.026_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.eururo.2008.06.032","article-title":"Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size","volume":"55","author":"Roehrborn","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.11.026_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1464-410X.2005.05889.x","article-title":"Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries","volume":"97","author":"Irwin","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2008.11.026_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-5347(01)65075-4","article-title":"The International Continence Society \u201cBenign Prostatic Hyperplasia\u201d study: the bothersomeness of urinary symptoms","volume":"157","author":"Peters","year":"1997","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808013596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808013596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T09:37:12Z","timestamp":1589189832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808013596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0302283808013596"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.11.026","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}